Pulmonary and Renal StateNCT04827017
Acute and Chronic Pulmonary and Renal Complications Following Contracting Severe Respiratory Distress Syndrome Coronavirus-19
An observational study of Pulmonary and Renal State, run by Minia University.
Trial summary
Tracking post- corona virus infection pulmonary and renal complications Read more about this study
- Who is it for?
- Ages 20 to 70 years
- Conditions the study is for
- Pulmonary and Renal State
- What is being tested?
- follow up
- How many people
- 1,000 participants
- Where
- No sites listed yet
- Study dates
- 5 Apr 2021to 10 Jul 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 70 years
- All sexes
- Adult, Older adult
Study population: All COVID positive population
Who may be able to join
- All COVID 19 patients admitted to ICU
Who cannot join
- Refusal to participate
About this study
Official title: Acute and Chronic Pulmonary and Renal Complications Following Contractiong Coronavirus Severe Respiratory Distress Syndrome.
Tracking post- corona virus infection pulmonary and renal complications
Read the detailed description
Mortality from pulmonary and renal system is highly noticable with COVID-19 pandemic . We trying to monitor compliction
- Conditions
- Pulmonary and Renal State
- Being tested
- follow up
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
follow upOther
follow up population
What is being measured
The primary outcome is the main question the study is designed to answer.
renal function
serum creatinine
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Apr 2021
- Study start5 Apr 2021 (estimated)
- Primary completion5 Jul 2021 (estimated)
- Study completion10 Jul 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pulmonary and Renal StateStudies of the same condition, open and under way.
- More trials run by Minia UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Minia University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mina Maher, Minia University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04827017
- Sponsor's protocol ID
- 278/3-2021
- Status last verified
- Mar 2021
- First submitted
- 29 Mar 2021
- Last updated
- 1 Apr 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Acute and Chronic Pulmonary and Renal Complications Following Contractiong Coronavirus Severe Respiratory Distress Syndrome.
- ClinicalTrials.gov ID
- NCT04827017
- Acronym / sponsor ID
- 278/3-2021
- Conditions
- Pulmonary and Renal State
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Minia UniversityUniversity, hospital or other
- Study start
- 5 Apr 2021 (estimated)
- Primary completion
- 5 Jul 2021 (estimated)
- Study completion
- 10 Jul 2021 (estimated)
- First posted
- 1 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Tracking post- corona virus infection pulmonary and renal complications
Detailed description
Mortality from pulmonary and renal system is highly noticable with COVID-19 pandemic . We trying to monitor compliction
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 20 to 70 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- All COVID positive population
Key inclusion criteria (1 listed)
- All COVID 19 patients admitted to ICU
Key exclusion criteria (1 listed)
- Refusal to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| follow upfollow up population | Other | – |
Primary outcome
renal function
Time frame: 12 weeks
serum creatinine
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Apr 2021.
Related trials for Pulmonary and Renal State
Enrolling by invitationObservational study
Multimodal Physiologic State Intelligence Study
Heart Failure, Cardiomyopathies
Active, not recruiting
The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease
Atherosclerosis, Chronic Kidney Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Pulmonary and Renal State, run by Minia University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 1 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
renal function (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2021.